1 week ago

Aurobindo Pharma Acquires US Research Firm for ₹127.32 Crore

Aurobindo Pharma has bought a US company called A1 Biochem Labs LLC.

It paid USD 15.247 million, or about ₹127.32 crore.

The deal was completed on October 2, 2026.

A1 Labs helps drug and biotechnology companies with research and chemistry work.

It will become a step-down subsidiary of A1 Labs India.

A1 Labs reported lower sales in 2025 than in 2024.

Aurobindo says the purchase will help it expand its work across the medicines ingredients business.

It also expects to build a dedicated research, development and manufacturing platform.

Key facts

Purchase price: USD 15.247 million, approximately ₹127.32 crore
Completion date: October 2, 2026
A1 Labs location: Wilmington, North Carolina, USA
2024 sales: USD 9.23 million
2025 sales: USD 5.92 million
Business: Contract research and chemistry services, including custom synthesis and medicinal chemistry
Regulatory approvals: The acquisition is not subject to governmental or regulatory approvals
Related-party status: The acquisition by A1 USA Inc is considered a related party transaction; A1 Labs LLC was acquired from Rajendra Gadikota, a director of A1 Labs India

freepressjournal.in · 1 week ago